Evaluation of fatigue


Key articles

National Institute for Health and Care Excellence​. Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management. Oct 2021 [internet publication].Full text

Centers for Disease Control and Prevention. Myalgic encephalomyelitis/chronic fatigue syndrome, etiology and pathophysiology. Jul 2018 [internet publication].Full text

Cornuz J, Guessous I, Favrat B. Fatigue: a practical approach to diagnosis in primary care. CMAJ. 2006 Mar 14;174(6):765-7.Full text  Abstract

Hamilton W, Watson J, Round A. Investigating fatigue in primary care. BMJ. 2010;341:c4259. Abstract

Reference articles

1. Chen MK. The epidemiology of self-perceived fatigue among adults. Prev Med. 1986 Jan;15(1):74-81. Abstract

2. Hickie IB, Hooker AW, Hadzi-Pavlovic D, et al. Fatigue in selected primary care settings: sociodemographic and psychiatric correlates. Med J Aust. 1996 May 20;164(10):585-8. Abstract

3. Wessely S, Chalder T, Hirsch S, et al. The prevalence and morbidity of chronic fatigue and chronic fatigue syndrome: a prospective primary care study. Am J Public Health. 1997 Sep;87(9):1449-55.Full text  Abstract

4. Kroenke K, Wood DR, Mangelsdorff AD, et al. Chronic fatigue in primary care. Prevalence, patient characteristics, and outcome. JAMA. 1988 Aug 19;260(7):929-34. Abstract

5. Skapinakis P, Lewis G, Meltzer H. Clarifying the relationship between unexplained chronic fatigue and psychiatric morbidity: results from a community survey in Great Britain. Int Rev Psychiatry. 2003 Feb-May;15(1-2):57-64. Abstract

6. Steele L, Dobbins JG, Fukuda K, et al. The epidemiology of chronic fatigue in San Francisco. Am J Med. 1998 Sep 28;105(3A):83S-90S. Abstract

7. Galland-Decker C, Marques-Vidal P, Vollenweider P. Prevalence and factors associated with fatigue in the Lausanne middle-aged population: a population-based, cross-sectional survey. BMJ Open. 2019 Aug 24;9(8):e027070.Full text  Abstract

8. Prins JB, van der Meer JW, Bleijenberg G. Chronic fatigue syndrome. Lancet. 2006 Jan 28;367(9507):346-55. Abstract

9. Wessely S, Chalder T, Hirsch S, et al. Psychological symptoms, somatic symptoms, and psychiatric disorder in chronic fatigue and chronic fatigue syndrome: a prospective study in the primary care setting. Am J Psychiatry. 1996 Aug;153(8):1050-9. Abstract

10. Cathebras PJ, Robbins JM, Kirmayer LJ, et al. Fatigue in primary care: prevalence, psychiatric comorbidity, illness behavior, and outcome. J Gen Intern Med. 1992 May-Jun;7(3):276-86. Abstract

11. Okkes IM, Oskam SK, Lamberts H. The probability of specific diagnoses for patients presenting with common symptoms to Dutch family physicians. J Fam Pract. 2002 Jan;51(1):31-6. Abstract

12. Walker EA, Katon WJ, Jemelka RP. Psychiatric disorders and medical care utilization among people in the general population who report fatigue. J Gen Intern Med. 1993 Aug;8(8):436-40. Abstract

13. Bates DW, Schmitt W, Buchwald D, et al. Prevalence of fatigue and chronic fatigue syndrome in a primary care practice. Arch Intern Med. 1993 Dec 27;153(24):2759-65. Abstract

14. Stadje R, Dornieden K, Baum E, et al. The differential diagnosis of tiredness: a systematic review. BMC Fam Pract. 2016 Oct 20;17(1):147.Full text  Abstract

15. Bensing JM, Hulsman RL, Schreurs KM. Gender differences in fatigue: biopsychosocial factors relating to fatigue in men and women. Med Care. 1999 Oct;37(10):1078-83. Abstract

16. Verdon F, Burnand B, Stubi CL, et al. Iron supplementation for unexplained fatigue in non-anaemic women: double blind randomised placebo controlled trial. BMJ. 2003 May 24;326(7399):1124.Full text  Abstract

17. Vaucher P, Druais PL, Waldvogel S, et al. Effect of iron supplementation on fatigue in nonanemic menstruating women with low ferritin: a randomized controlled trial. CMAJ. 2012 Aug 7;184(11):1247-54. Abstract

18. Fukuda K, Straus SE, Hickie I, et al. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med. 1994 Dec 15;121(12):953-9. Abstract

19. Reid S, Chalder T, Cleare A, et al. Chronic fatigue syndrome. BMJ. 2000 Jan 29;320(7230):292-6.Full text  Abstract

20. Buchwald D, Umali P, Umali J, et al. Chronic fatigue and the chronic fatigue syndrome: prevalence in a Pacific Northwest health care system. Ann Intern Med. 1995 Jul 15;123(2):81-8. Abstract

21. Darbishire L, Ridsdale L, Seed PT. Distinguishing patients with chronic fatigue from those with chronic fatigue syndrome: a diagnostic study in UK primary care. Br J Gen Pract. 2003 Jun;53(491):441-5.Full text  Abstract

22. Ridsdale L, Evans A, Jerrett W, et al. Patients with fatigue in general practice: a prospective study. BMJ. 1993 Jul 10;307(6896):103-6.Full text  Abstract

23. Institute of Medicine. Beyond myalgic encephalomyelitis/chronic fatigue syndrome: redefining an illness. Washington, DC: The National Academies Press; 2015.

24. Ohayon MM. Prevalence of DSM-IV diagnostic criteria of insomnia: distinguishing insomnia related to mental disorders from sleep disorders. J Psychiatr Res. 1997 May-Jun;31(3):333-46. Abstract

25. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th ed., text revision (DSM-5-TR). Washington, DC: American Psychiatric Publishing; 2022.

26. National Institute for Health and Care Excellence. Obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over 16s. Aug 2021 [internet publication].Full text

27. Hornyak M, Kopasz M, Berger M, et al. Impact of sleep-related complaints on depressive symptoms in patients with restless legs syndrome. J Clin Psychiatry. 2005 Sep;66(9):1139-45. Abstract

28. Cuellar NG, Strumpf NE, Ratcliffe SJ. Symptoms of restless legs syndrome in older adults: outcomes on sleep quality, sleepiness, fatigue, depression, and quality of life. J Am Geriatr Soc. 2007 Sep;55(9):1387-92. Abstract

29. Lawrie SM, Pelosi AJ. Chronic fatigue syndrome in the community. Prevalence and associations. Br J Psychiatry. 1995 Jun;166(6):793-7. Abstract

30. Krayenbuehl PA, Battegay E, Breymann C, et al. Intravenous iron for the treatment of fatigue in nonanemic, premenopausal women with low serum ferritin concentration. Blood. 2011 Sep 22;118(12):3222-7.Full text  Abstract

31. Favrat B, Balck K, Breymann C, et al. Evaluation of a single dose of ferric carboxymaltose in fatigued, iron-deficient women--PREFER a randomized, placebo-controlled study. PLoS One. 2014 Apr 21;9(4):e94217.Full text  Abstract

32. Drexler H, Coats AJ. Explaining fatigue in congestive heart failure. Annu Rev Med. 1996;47:241-56. Abstract

33. Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2016 Jul 14;37(27):2129-200.Full text  Abstract

34. McSweeney JC, Cody M, O'Sullivan P, et al. Women's early warning symptoms of acute myocardial infarction. Circulation. 2003 Nov 25;108(21):2619-23.Full text  Abstract

35. Blakeman JR, Stapleton SJ. An integrative review of fatigue experienced by women before and during myocardial infarction. J Clin Nurs. 2018 Mar;27(5-6):906-16.Full text  Abstract

36. Khan NA, Daskalopoulou SS, Karp I, et al. Sex differences in acute coronary syndrome symptom presentation in young patients. JAMA Intern Med. 2013 Nov 11;173(20):1863-71. Abstract

37. Crea F, Battipaglia I, Andreotti F, et al. Sex differences in mechanisms, presentation and management of ischaemic heart disease. Atherosclerosis. 2015 Jul;241(1):157-68. Abstract

38. Canaris GJ, Manowitz NR, Mayor G, et al. The Colorado thyroid disease prevalence study. Arch Intern Med. 2000 Feb 28;160(4):526-34. Abstract

39. Biondi B, Cappola AR, Cooper DS. Subclinical Hypothyroidism: A Review. JAMA. 2019 Jul 9;322(2):153-60.Full text  Abstract

40. Levy-Marchal C, Patterson CC, Green A, et al. Geographical variation of presentation at diagnosis of type I diabetes in children: the EURODIAB study. European and Diabetes. Diabetologia. 2001 Oct;44(suppl 3):B75-80. Abstract

41. Lovas K, Loge JH, Husebye ES. Subjective health status in Norwegian patients with Addison's disease. Clin Endocrinol (Oxf). 2002 May;56(5):581-8. Abstract

42. Biermasz NR, van Thiel SW, Pereira AM, et al. Decreased quality of life in patients with acromegaly despite long-term cure of growth hormone excess. J Clin Endocrinol Metab. 2004 Nov;89(11):5369-76.Full text  Abstract

43. Wallymahmed ME, Foy P, MacFarlane IA. The quality of life of adults with growth hormone deficiency: comparison with diabetic patients and control subjects. Clin Endocrinol (Oxf). 1999 Sep;51(3):333-8. Abstract

44. Aronson MD, Komaroff AL, Pass TM, et al. Heterophil antibody in adults with sore throat: frequency and clinical presentation. Ann Intern Med. 1982 Apr;96(4):505-8. Abstract

45. Barroso J. A review of fatigue in people with HIV infection. J Assoc Nurses AIDS Care. 1999 Sep-Oct;10(5):42-9. Abstract

46. Crook H, Raza S, Nowell J, et al. Long covid-mechanisms, risk factors, and management. BMJ. 2021 Jul 26;374:n1648.Full text  Abstract

47. Chen C, Haupert SR, Zimmermann L, et al. Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or long COVID: a meta-analysis and systematic review. J Infect Dis. 2022 Nov 1;226(9):1593-607.Full text  Abstract

48. Nadelman RB, Nowakowski J, Forseter G, et al. The clinical spectrum of early Lyme borreliosis in patients with culture-confirmed erythema migrans. Am J Med. 1996 May;100(5):502-8. Abstract

49. Cairns V, Godwin J. Post-Lyme borreliosis syndrome: a meta-analysis of reported symptoms. Int J Epidemiol. 2005 Dec;34(6):1340-5.Full text  Abstract

50. Berende A, ter Hofstede HJ, Vos FJ, et al. Randomized Trial of Longer-Term Therapy for Symptoms Attributed to Lyme Disease. N Engl J Med. 2016 Mar 31;374(13):1209-20.Full text  Abstract

51. Monto AS, Gravenstein S, Elliott M, et al. Clinical signs and symptoms predicting influenza infection. Arch Intern Med. 2000 Nov 27;160(21):3243-7.Full text  Abstract

52. Revol B, Jullian-Desayes I, Tamisier R, et al. Ticagrelor and Central Sleep Apnea. J Am Coll Cardiol. 2018 May 22;71(20):2378-9.Full text  Abstract

53. Clarkson TW, Magos L, Myers GJ. The toxicology of mercury - current exposures and clinical manifestations. N Engl J Med. 2003 Oct 30;349(18):1731-7. Abstract

54. Leikin JB, Karydes HC, Whiteley PM, et al. Outpatient toxicology clinic experience of patients with hip implants. Clin Toxicol (Phila). 2013 May;51(4):230-6. Abstract

55. Breslin E, van der Schans C, Breukink S, et al. Perception of fatigue and quality of life in patients with COPD. Chest. 1998 Oct;114(4):958-64. Abstract

56. Guyatt GH, Berman LB, Townsend M, et al. A measure of quality of life for clinical trials in chronic lung disease. Thorax. 1987 Oct;42(10):773-8.Full text  Abstract

57. Wijkstra PJ, Van Altena R, Kraan J, et al. Quality of life in patients with chronic obstructive pulmonary disease improves after rehabilitation at home. Eur Respir J. 1994 Feb;7(2):269-73.Full text  Abstract

58. Humbert M, Kovacs G, Hoeper MM, et al. 2022 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2022 Oct 11;43(38):3618-731.Full text

59. Alsina-Restoy X, Torres-Castro R, Caballería E, et al. Pulmonary rehabilitation in sarcoidosis: a systematic review and meta-analysis. Respir Med. 2023 Nov-Dec;219:107432. Abstract

60. Atkins C, Wilson AM. Managing fatigue in sarcoidosis - a systematic review of the evidence. Chron Respir Dis. 2017 May;14(2):161-73.Full text  Abstract

61. Farrell RJ, Kelly CP. Celiac sprue. N Engl J Med. 2002 Jan 17;346(3):180-8. Abstract

62. Jelsness-Jørgensen LP, Bernklev T, Lundin KEA. Fatigue as an Extra-Intestinal Manifestation of Celiac Disease: A Systematic Review. Nutrients. 2018 Nov 3;10(11):.Full text  Abstract

63. Goldblatt J, Taylor PJ, Lipman T, et al. The true impact of fatigue in primary biliary cirrhosis: a population study. Gastroenterology. 2002 May;122(5):1235-41. Abstract

64. Foster GR, Goldin RD, Thomas HC. Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis. Hepatology. 1998 Jan;27(1):209-12. Abstract

65. Witt-Sullivan H, Heathcote J, Cauch K, et al. The demography of primary biliary cirrhosis in Ontario, Canada. Hepatology. 1990 Jul;12(1):98-105. Abstract

66. Grimstad T, Norheim KB. Fatigue in inflammatory bowel disease. [in nor]. Tidsskr Nor Laegeforen. 2016 Nov;136(20):1721-4.Full text  Abstract

67. Han CJ, Yang GS. Fatigue in Irritable Bowel Syndrome: A Systematic Review and Meta-analysis of Pooled Frequency and Severity of Fatigue. Asian Nurs Res (Korean Soc Nurs Sci). 2016 Mar;10(1):1-10.Full text  Abstract

68. Laupacis A, Muirhead N, Keown P, et al. A disease-specific questionnaire for assessing quality of life in patients on hemodialysis. Nephron. 1992;60(3):302-6. Abstract

69. McCann K, Boore JR. Fatigue in persons with renal failure who require maintenance haemodialysis. J Adv Nurs. 2000 Nov;32(5):1132-42. Abstract

70. Krupp LB, Pollina DA. Mechanisms and management of fatigue in progressive neurological disorders. Curr Opin Neurol. 1996 Dec;9(6):456-60. Abstract

71. Karlsen K, Larsen JP, Tandberg E, et al. Fatigue in patients with Parkinsons disease. Mov Disord. 1999 Mar;14(2):237-41. Abstract

72. Beiske AG, Svensson E. Fatigue in Parkinson's disease: a short update. Acta Neurol Scand Suppl. 2010;(190):78-81. Abstract

73. Staub F, Bogousslavsky J. Fatigue after stroke: a major but neglected issue. Cerebrovasc Dis. 2001 Aug;12(2):75-81. Abstract

74. Cumming TB, Yeo AB, Marquez J, et al. Investigating post-stroke fatigue: An individual participant data meta-analysis. J Psychosom Res. 2018 Oct;113:107-12.Full text  Abstract

75. van der Werf SP, Jongen PJ, Lycklama a Nijeholt GJ, et al. Fatigue in multiple sclerosis: interrelations between fatigue complaints, cerebral MRI abnormalities and neurological disability. J Neurol Sci. 1998 Oct 8;160(2):164-70. Abstract

76. Vercoulen JH, Hommes OR, Swanink CM, et al. The measurement of fatigue in patients with multiple sclerosis. A multidimensional comparison with patients with chronic fatigue syndrome and healthy subjects. Arch Neurol. 1996 Jul;53(7):642-9. Abstract

77. Colombo B, Martinelli Boneschi F, Rossi P, et al. MRI and motor evoked potential findings in nondisabled multiple sclerosis patients with and without symptoms of fatigue. J Neurol. 2000 Jul;247(7):506-9. Abstract

78. Krupp LB, LaRocca NG, Muir J, et al. A study of fatigue in systemic lupus erythematosus. J Rheumatol. 1990 Nov;17(11):1450-2. Abstract

79. Omdal R, Waterloo K, Koldingsnes W, et al. Fatigue in patients with systemic lupus erythematosus: the psychosocial aspects. J Rheumatol. 2003 Feb;30(2):283-7. Abstract

80. Riemsma RP, Rasker JJ, Taal E, et al. Fatigue in rheumatoid arthritis: the role of self-efficacy and problematic social support. Br J Rheumatol. 1998 Oct;37(10):1042-6. Abstract

81. Stone P, Richardson A, Ream E, et al. Cancer-related fatigue: inevitable, unimportant and untreatable? Results of a multi-centre patient survey. Cancer Fatigue Forum. Ann Oncol. 2000 Aug;11(8):971-5. Abstract

82. Levy M. Cancer fatigue: a review for psychiatrists. Gen Hosp Psychiatry. 2008 May-Jun;30(3):233-44. Abstract

83. Cella D, Lai JS, Chang CH, et al. Fatigue in cancer patients compared with fatigue in the general United States population. Cancer. 2002 Jan 15;94(2):528-38.Full text  Abstract

84. Harter M, Reuter K, Aschenbrenner A, et al. Psychiatric disorders and associated factors in cancer: results of an interview study with patients in inpatient, rehabilitation and outpatient treatment. Eur J Cancer. 2001 Jul;37(11):1385-93. Abstract

85. National Institute for Health and Care Excellence​. Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management. Oct 2021 [internet publication].Full text

86. Muller AE, Tveito K, Bakken IJ, et al. Potential causal factors of CFS/ME: a concise and systematic scoping review of factors researched. J Transl Med. 2020 Dec 14;18(1):484.Full text  Abstract

87. Huth TK, Eaton-Fitch N, Staines D, et al. A systematic review of metabolomic dysregulation in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis/Systemic Exertion Intolerance Disease (CFS/ME/SEID). J Transl Med. 2020 May 13;18(1):198.Full text  Abstract

88. Centers for Disease Control and Prevention. Myalgic encephalomyelitis/chronic fatigue syndrome, etiology and pathophysiology. Jul 2018 [internet publication].Full text

89. Miller RR, Uyaguari-Diaz M, McCabe MN, et al. Metagenomic Investigation of Plasma in Individuals with ME/CFS Highlights the Importance of Technical Controls to Elucidate Contamination and Batch Effects. PLoS One. 2016;11(11):e0165691.Full text  Abstract

90. Bombardier CH, Buchwald D. Chronic fatigue, chronic fatigue syndrome, and fibromyalgia. Disability and health-care use. Med Care. 1996 Sep;34(9):924-30. Abstract

91. Cornuz J, Guessous I, Favrat B. Fatigue: a practical approach to diagnosis in primary care. CMAJ. 2006 Mar 14;174(6):765-7.Full text  Abstract

92. Lane TJ, Matthews DA, Manu P. The low yield of physical examinations and laboratory investigations of patients with chronic fatigue. Am J Med Sci. 1990 May;299(5):313-8. Abstract

93. Ridsdale L, Evans A, Jerrett W, et al. Patients who consult with tiredness: frequency of consultation, perceived causes of tiredness and its association with psychological distress. Br J Gen Pract. 1994 Sep;44(386):413-6.Full text  Abstract

94. Hamilton W, Watson J, Round A. Investigating fatigue in primary care. BMJ. 2010;341:c4259. Abstract

95. Wright J, O'Connor KM. Fatigue. Med Clin North Am. 2014 May;98(3):597-608. Abstract

96. Yu DS, Lee DT, Man NW. Fatigue among older people: a review of the research literature. Int J Nurs Stud. 2010 Feb;47(2):216-28. Abstract

97. Guidelines and Protocols Advisory Committee, British Columbia Medical Services Commission. Iron deficiency: diagnosis and management. April 2019 [internet publication].Full text

98. Ebell MH, Belden JL. Clinical inquiries. What is a reasonable initial approach to the patient with fatigue? J Fam Pract. 2001 Jan;50(1):16-7. Abstract

99. Kroenke K, Spitzer RL, Williams JB. The patient health questionnaire-2: validity of a two-item depression screener. Med Care. 2003 Nov;41(11):1284-92. Abstract

100. Spitzer RL, Williams JB, Kroenke K, et al. Utility of a new procedure for diagnosing mental disorders in primary care: the PRIME-MD 1000 study. JAMA. 1994 Dec 14;272(22):1749-56. Abstract

101. Jackson JL, Houston JS, Hanling SR, et al. Clinical predictors of mental disorders among medical outpatients. Arch Intern Med. 2001 Mar 26;161(6):875-9.Full text  Abstract

102. Spitzer RL, Kroenke K, Williams JB; Patient Health Questionnaire Primary Care Study Group. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. JAMA. 1999 Nov 10;282(18):1737-44.Full text  Abstract

103. Ewing JA. Detecting alcoholism: the CAGE questionnaire. JAMA. 1984 Oct 12;252(14):1905-7. Abstract

104. Babor TF, Higgins-Biddle JC, Saunders JB, et al. The alcohol use disorders identification test: guidelines for use in primary care. 2nd ed. World Health Organization. Department of Mental Health and Substance Dependence. Geneva, Switzerland: WHO; 2001.Full text

105. Violani C, Devoto A, Lucidi F, et al. Validity of a short insomnia questionnaire: the SDQ. Brain Res Bull. 2004 Jun 30;63(5):415-21. Abstract

106. Nguyen AT, Baltzan MA, Small D, et al. Clinical reproducibility of the Epworth Sleepiness Scale. J Clin Sleep Med. 2006 Apr 15;2(2):170-4. Abstract

107. Rosenthal LD, Dolan DC. The Epworth sleepiness scale in the identification of obstructive sleep apnea. J Nerv Ment Dis. 2008 May;196(5):429-31. Abstract

108. Whitehead L. The measurement of fatigue in chronic illness: a systematic review of unidimensional and multidimensional fatigue measures. J Pain Symptom Manage. 2009 Jan;37(1):107-28. Abstract

109. Mendoza TR, Wang XS, Cleeland CS, et al. The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer. 1999 Mar 1;85(5):1186-96. Abstract

110. Krupp LB, LaRocca NG, Muir-Nash J, et al. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989 Oct;46(10):1121-3. Abstract

111. Hann DM, Jacobsen PB, Azzarello LM, et al. Measurement of fatigue in cancer patients: development and validation of the Fatigue Symptom Inventory. Qual Life Res. 1998 May;7(4):301-10. Abstract

112. Belza B, Miyawaki CE, Liu M, et al. A Systematic Review of Studies Using the Multidimensional Assessment of Fatigue Scale. J Nurs Meas. 2018 Apr 1;26(1):36-75.Full text  Abstract

113. Kalra L, Hamlyn AN, Jones BJ. Blue sclerae: a common sign of iron deficiency? Lancet. 1986 Nov 29;2(8518):1267-9. Abstract

114. Prabhakar VK, Shalet SM. Aetiology, diagnosis, and management of hypopituitarism in adult life. Postgrad Med J. 2006 Apr;82(966):259-66.Full text  Abstract

115. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the Multicenter Criteria Committee. Arthritis Rheum. 1990 Feb;33(2):160-72. Abstract

116. ​Centers for Disease Control and Prevention. Signs and symptoms of untreated Lyme disease. Jan 2021 [internet publication]Full text

117. Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022 May 3;145(18):e895-e1032.Full text  Abstract

118. Anton RF, Moak DH. Carbohydrate-deficient transferrin and gamma-glutamyltransferase as markers of heavy alcohol consumption: gender differences. Alcohol Clin Exp Res. 1994 Jun;18(3):747-54. Abstract

119. Hanna FWF, Issa BG, Kevil B, et al. Investigating cortisol excess or deficiency: a practical approach. BMJ. 2019 Nov 26;367:l6039.Full text  Abstract

120. Oelkers W. Hyponatremia and inappropriate secretion of vasopressin (antidiuretic hormone) in patients with hypopituitarism. N Engl J Med. 1989 Aug 24;321(8):492-6. Abstract

121. Centers for Disease Control and Prevention. Evaluating and caring for patients with post-COVID conditions: interim guidance. Jun 2021 [internet publication].Full text

122. National Institute for Health and Care Excellence. COVID-19 rapid guideline: managing the long-term effects of COVID-19. Jan 2024 [internet publication].Full text

123. Mulrow CD, Williams JW Jr, Gerety MB, et al. Case-finding instruments for depression in primary care settings. Ann Intern Med. 1995 Jun 15;122(12):913-21. Abstract

124. Rushton DH, Norris MJ, Dover R, et al. Causes of hair loss and the developments in hair rejuvenation. Int J Cosmet Sci. 2002 Feb;24(1):17-23. Abstract

125. Trost LB, Bergfeld WF, Calogeras E. The diagnosis and treatment of iron deficiency and its potential relationship to hair loss. J Am Acad Dermatol. 2006 May;54(5):824-44. Abstract

126. American Academy of Sleep Medicine. International classification of sleep disorders - third edition, text revision (ICSD-3-TR). Westchester, IL: American Academy of Sleep Medicine; 2023.

127. Gibson GJ. Obstructive sleep apnoea syndrome: underestimated and undertreated. Br Med Bull. 2005 Mar 29;72:49-65.Full text  Abstract

128. American Academy of Sleep Medicine. The AASM manual for the scoring of sleep and associated events. Feb 2023 [internet publication].Full text

129. Erratum: Evaluation and management of obesity hypoventilation syndrome. An official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med. 2019 Nov 15;200(10):1326.Full text

130. Mokhlesi B, Masa JF, Brozek JL, et al. Evaluation and management of obesity hypoventilation syndrome. An official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med. 2019 Aug 1;200(3):e6-24.Full text  Abstract

131. Mokhlesi B, Tulaimat A, Faibussowitsch I, et al. Obesity hypoventilation syndrome: prevalence and predictors in patients with obstructive sleep apnea. Sleep Breath. 2007 Jun;11(2):117-24. Abstract

132. Sivam S, Yee B, Wong K, et al. Obesity hypoventilation syndrome: early detection of nocturnal-only hypercapnia in an obese population. J Clin Sleep Med. 2018 Sep 15;14(9):1477-84.Full text  Abstract

133. American Diabetes Association Professional Practice Committee. 2. Diagnosis and classification of diabetes: standards of care in diabetes-2024. Diabetes Care. 2024 Jan 1;47(suppl 1):S20-42.Full text  Abstract

134. Centers for Disease Control and Prevention. Influenza signs and symptoms and the role of laboratory diagnostics. October 2016 [internet publication].Full text

135. Lewinsohn DM, Leonard MK, LoBue PA, et al. Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention clinical practice guidelines: diagnosis of tuberculosis in adults and children. Clin Infect Dis. 2017 Jan 15;64(2):111-5.Full text  Abstract

136. Geldmacher H, Taube C, Kroeger C, et al. Assessment of lymph node tuberculosis in northern Germany: a clinical review. Chest. 2002 Apr;121(4):1177-82.Full text  Abstract

137. Weir MR, Thornton GF. Extrapulmonary tuberculosis. Experience of a community hospital and review of the literature. Am J Med. 1985 Oct;79(4):467-78.Full text  Abstract

138. Baydur A. The spectrum of extrapulmonary tuberculosis. West J Med. 1977 Apr;126(4):253-62.Full text  Abstract

139. Nataraj G, Kurup S, Pandit A, et al. Correlation of fine needle aspiration cytology, smear and culture in tuberculous lymphadenitis: a prospective study. J Postgrad Med. 2002 Apr-Jun;48(2):113-6.Full text  Abstract

140. Centers for Disease Control and Prevention. Updated guidelines for the use of nucleic acid amplification tests in the diagnosis of tuberculosis. Jan 2009 [internet publication].Full text

141. World Health Organization. WHO consolidated guidelines on tuberculosis. Module 3: diagnosis: rapid diagnostics for tuberculosis detection. Mar 2024 [internet publication].Full text

142. Bjerrum S, Schiller I, Dendukuri N, et al. Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in people living with HIV. Cochrane Database Syst Rev. 2019 Oct 21;10(10):CD011420.Full text  Abstract

143. Dickstein G, Shechner C, Nicholson WE, et al. Adrenocorticotropin stimulation test: effects of basal cortisol level, time of day, and suggested new sensitive low dose test. J Clin Endocrinol Metab. 1991 Apr;72(4):773-8. Abstract

144. Mead P, Petersen J, Hinckley A. Updated CDC Recommendation for Serologic Diagnosis of Lyme Disease. MMWR Morb Mortal Wkly Rep. 2019 Aug 16;68(32):703.Full text  Abstract

145. Hedman K, Lappalainen M, Seppala I, et al. Recent primary toxoplasma infection indicated by a low avidity of specific IgG.J Infect Dis. 1989 Apr;159(4):736-40. Abstract

146. Perazella MA, Reilly RF. Chronic kidney disease: a new classification and staging system. Hospital Physician. 2003 Mar;39:18-45.

147. Hughes AJ, Daniel SE, Kilford L, et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992 Mar;55(3):181-4.Full text  Abstract

148. Smeenk R, Brinkman K, van den Brink H, et al. Antibodies to DNA in patients with systemic lupus erythematosus: their role in the diagnosis, the follow-up and the pathogenesis of the disease. Clin Rheumatol. 1990 Mar;9(1 suppl 1):100-10. Abstract

149. Eaton RB, Schnneider G, Schur PH. Enzyme immunoassay for antibodies to native DNA. Specificity and quality of antibodies. Arthritis Rheum. 1983 Jan;26(1):52-62. Abstract

Use of this content is subject to our disclaimer